April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Voriconazole Penetration In An Ex-vivo Porcine Eye Model After Cornel Crosslinking
Author Affiliations & Notes
  • Beatrice E. Frueh
    Ophthalmology, Univ of Bern Inselspital, Bern, Switzerland
  • Markus Tschopp
    Ophthalmology, Univ of Bern Inselspital, Bern, Switzerland
  • Johannes Stary
    Ophthalmology, Univ of Bern Inselspital, Bern, Switzerland
  • Christoph Tappeiner
    Ophthalmology, Univ of Bern Inselspital, Bern, Switzerland
  • Footnotes
    Commercial Relationships  Beatrice E. Frueh, None; Markus Tschopp, None; Johannes Stary, None; Christoph Tappeiner, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2546. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Beatrice E. Frueh, Markus Tschopp, Johannes Stary, Christoph Tappeiner; Voriconazole Penetration In An Ex-vivo Porcine Eye Model After Cornel Crosslinking. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2546.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze the influence of corneal crosslinking (CXL) on penetration of topically applied voriconazole.

Methods: : In an ex-vivo porcine eye model, corneas were crosslinked (group 1, n=27 eyes) performing a corneal abrasion, applying riboflavin 5 mg/ml drops every 5 minutes for 30 minutes and irradiating with UVA (370 nm, 3 mW/cm2 for 30 minutes). Afterwards, eyes were rinsed with balanced salt solution (BSS). Voriconazole eye drops (10mg/ml) were topically applied onto the cornea every 5 minutes for a total of 30 minutes. In a control group (n=27 eyes) corneal abrasion and riboflavin application were performed equally, but without following UVA irradiation. Central corneal thickness and anterior chamber depth were measured using a Pentacam Scheimpflug device. In both groups, anterior chamber taps and voriconazole HPLC analysis from aqueous humor were performed.

Results: : Concentration of voriconazole in the anterior chamber was significantly lower in the eyes with previous CXL (mean 54.7±9.0 µg/ml) than in the untreated group (mean 62.9±13.0 µg/ml, p=0.01). Corneal thickness and anterior chamber volume were comparable in both groups (p>0.50, each).

Conclusions: : CXL seems to reduce the penetration of topical applied voriconazole.

Keywords: cornea: basic science • keratoconus • fungal disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×